Recurrence breast cancers receptor erbb 2. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Breast Cell Line, Tumor MCF-7 Cells Tumor Cells, Cultured Axilla Mammary Glands, Human Lymph Nodes Neoplastic Stem Cells Nipples Neoplastic Cells, Circulating Epithelial Cells Mammary Glands, Animal Cell Line

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases47

Recurrence Neoplasm Recurrence, Local Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms, Male Carcinoma, Lobular Lymphatic Metastasis Carcinoma, Intraductal, Noninfiltrating Carcinoma Genetic Predisposition to Disease Mammary Neoplasms, Experimental Ovarian Neoplasms Neoplasms, Hormone-Dependent Lung Neoplasms Disease Progression Prostatic Neoplasms Neoplasms Bone Neoplasms Fibrocystic Breast Disease Colonic Neoplasms Adenocarcinoma Stomach Neoplasms Carcinoma in Situ Cell Transformation, Neoplastic Carcinoma, Ductal Neoplasms, Second Primary Inflammatory Breast Neoplasms Triple Negative Breast Neoplasms Liver Neoplasms Pancreatic Neoplasms Urinary Bladder Neoplasms Colorectal Neoplasms Carcinoma, Squamous Cell Uterine Cervical Neoplasms Neoplastic Cells, Circulating Rectal Neoplasms Neovascularization, Pathologic Fibroadenoma Neoplasms, Multiple Primary Endometrial Neoplasms Neoplasms, Basal Cell Neoplasms, Radiation-Induced Carcinoma, Non-Small-Cell Lung Pregnancy Complications, Neoplastic

Chemicals and Drugs60

Neuregulin-1 Neuregulins Receptor, erbB-3 Receptor, erbB-2 Receptor, Epidermal Growth Factor Epidermal Growth Factor Receptors, Estrogen Tamoxifen Receptors, Progesterone Tumor Markers, Biological Antineoplastic Agents, Hormonal Antineoplastic Agents Neoplasm Proteins Estrogen Receptor alpha Estrogens RNA, Messenger BRCA2 Protein Aromatase Inhibitors Estrogen Antagonists BRCA1 Protein DNA, Neoplasm Antibodies, Monoclonal, Humanized Fluorouracil RNA, Small Interfering Estradiol Estrogen Receptor Modulators Cyclophosphamide Antibodies, Monoclonal Tumor Suppressor Protein p53 Nitriles Ki-67 Antigen Selective Estrogen Receptor Modulators Epirubicin Oncogene Proteins v-erbB Tumor Suppressor Proteins Paclitaxel Antigens, Neoplasm RNA, Neoplasm Cancer Vaccines Quinazolines Proto-Oncogene Proteins c-akt Triazoles Anticarcinogenic Agents Mucin-1 Antigens, CD24 Transcription Factors Antibiotics, Antineoplastic Proto-Oncogene Proteins MicroRNAs Anthracyclines DNA-Binding Proteins Doxorubicin Prostate-Specific Antigen Cyclin D1 Methotrexate Phosphatidylinositol 3-Kinases Cisplatin Protein-Serine-Threonine Kinases Protein Kinase Inhibitors Nuclear Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment73

Prognosis Mammography Neoplasm Staging Risk Factors Follow-Up Studies Mastectomy Chemotherapy, Adjuvant Disease-Free Survival Treatment Outcome Retrospective Studies Early Detection of Cancer Survival Analysis Survival Rate Antineoplastic Combined Chemotherapy Protocols Immunohistochemistry Prospective Studies Case-Control Studies Mammary Neoplasms, Experimental Gene Expression Profiling Risk Mastectomy, Segmental Risk Assessment Reverse Transcriptase Polymerase Chain Reaction Breast Self-Examination Incidence Multivariate Analysis Combined Modality Therapy Odds Ratio Kaplan-Meier Estimate Cohort Studies Blotting, Western Predictive Value of Tests Xenograft Model Antitumor Assays Sensitivity and Specificity Radiotherapy, Adjuvant Registries Oligonucleotide Array Sequence Analysis Neoplasm Transplantation Transplantation, Heterologous Tissue Array Analysis Tumor Burden Proportional Hazards Models Neoplasm Grading Ultrasonography, Mammary Logistic Models Questionnaires SEER Program Transfection Reproducibility of Results Neoadjuvant Therapy Polymerase Chain Reaction Breast Implants Immunoenzyme Techniques Lymph Node Excision Clinical Trials as Topic Radiotherapy Confidence Intervals Mammaplasty Biopsy Mass Screening Drug Administration Schedule Biopsy, Needle Sentinel Lymph Node Biopsy Molecular Targeted Therapy Genetic Testing In Situ Hybridization, Fluorescence Drug Screening Assays, Antitumor Gene Knockdown Techniques Mastectomy, Radical Estrogen Replacement Therapy Models, Biological DNA Mutational Analysis Tomography, X-Ray Computed

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes51

Genes, erbB Gene Expression Regulation, Neoplastic Genes, BRCA1 Postmenopause Genes, erbB-2 Drug Resistance, Neoplasm Genetic Predisposition to Disease Cell Proliferation Premenopause Risk Breast Feeding Time Factors Menopause Signal Transduction Genes, BRCA2 Odds Ratio Mutation Apoptosis Sensitivity and Specificity Cell Movement Cell Division Genotype Down-Regulation Gene Amplification Germ-Line Mutation Transfection Cell Growth Processes Polymorphism, Genetic Phosphorylation Promoter Regions, Genetic DNA Methylation Dose-Response Relationship, Drug Cell Cycle RNA Interference Up-Regulation Cell Survival Gene Expression Parity Phenotype Gene Silencing Base Sequence Genes, Neoplasm Genes, Tumor Suppressor Epithelial-Mesenchymal Transition Genes, p53 Alleles Diet Heterozygote Drug Synergism Polymorphism, Single Nucleotide Transcription, Genetic

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries Questionnaires SEER Program Base Sequence Molecular Sequence Data

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care32

Risk Factors Follow-Up Studies Disease-Free Survival Treatment Outcome Retrospective Studies Survival Analysis Survival Rate Prospective Studies Case-Control Studies Risk Risk Assessment Incidence Age Factors Multivariate Analysis Odds Ratio Kaplan-Meier Estimate Cohort Studies Predictive Value of Tests Sensitivity and Specificity Registries Proportional Hazards Models Logistic Models Questionnaires SEER Program Reproducibility of Results Clinical Trials as Topic Confidence Intervals Mass Screening Genetic Testing Parity National Cancer Institute (U.S.)Age of Onset

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Neuregulin-1 Neuregulins Receptor, erbB-3 Receptor, erbB-2 Receptor, Epidermal Growth Factor Breast Recurrence Neoplasm Recurrence, Local Breast Neoplasms Carcinoma, Ductal, Breast Epidermal Growth Factor Receptors, Estrogen Genes, erbB Cell Line, Tumor Prognosis Breast Diseases Tamoxifen Gene Expression Regulation, Neoplastic Receptors, Progesterone Neoplasm Metastasis Neoplasm Invasiveness Mammography Tumor Markers, Biological Neoplasm Staging Risk Factors Antineoplastic Agents, Hormonal Follow-Up Studies Mastectomy Chemotherapy, Adjuvant Breast Neoplasms, Male Antineoplastic Agents Disease-Free Survival Treatment Outcome Retrospective Studies Early Detection of Cancer Survival Analysis Neoplasm Proteins Carcinoma, Lobular Genes, BRCA1 Postmenopause Lymphatic Metastasis Carcinoma, Intraductal, Noninfiltrating Survival Rate Carcinoma Antineoplastic Combined Chemotherapy Protocols Immunohistochemistry Mice, Nude Genes, erbB-2 MCF-7 Cells Drug Resistance, Neoplasm Tumor Cells, Cultured Genetic Predisposition to Disease Prospective Studies Case-Control Studies Cell Proliferation Mammary Neoplasms, Experimental Gene Expression Profiling Premenopause Risk Estrogen Receptor alpha Breast Feeding Ovarian Neoplasms Estrogens Neoplasms, Hormone-Dependent Mastectomy, Segmental Risk Assessment Time Factors Reverse Transcriptase Polymerase Chain Reaction Breast Self-Examination Lung Neoplasms Disease Progression Prostatic Neoplasms RNA, Messenger Menopause Signal Transduction Incidence Age Factors BRCA2 Protein Aromatase Inhibitors Axilla Genes, BRCA2 Survivors Neoplasms Multivariate Analysis Estrogen Antagonists BRCA1 Protein Combined Modality Therapy Odds Ratio Kaplan-Meier Estimate Bone Neoplasms Cohort Studies Fibrocystic Breast Disease Mammary Glands, Human DNA, Neoplasm Mutation Blotting, Western Predictive Value of Tests Xenograft Model Antitumor Assays Apoptosis Antibodies, Monoclonal, Humanized

No FAQ available that match "recurrence breast cancers receptor erbb 2"